Nitrosamine Method Development
Supporting Regulatory-Driven Excellence in Pharmaceutical and Medical Device Testing
Gateway Analytical provides advanced R&D-stage LC-MS/MS workflows purpose-built to meet FDA, EMA, and ICH M7 guidelines for genotoxic impurity analysis. Our scientists apply deep regulatory insight and scientific precision to deliver accurate, defensible results that support risk assessment and regulatory filings. With flexible, client-directed validation options, our workflows can seamlessly transition from exploratory to validated use.
Choose Gateway for unmatched analytical expertise, regulatory alignment, and a partner committed to accelerating your product development with confidence.


Covering every stage of the drug development journey with our state-of-the-art, FDA-inspected, cGMP-compliant facilities designed to minimize bottlenecks and maximize success.